QLGN - Qualigen Therapeutics Inc
Previous close
0.185
0 0%
Share volume: 112,953
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.18
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-7.45%
1 Month
-13.27%
3 Months
-31.33%
6 Months
-60.09%
1 Year
-81.05%
2 Year
-95.19%
Key data
Stock price
$0.18
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.14 - $1.10
52 WEEK CHANGE
-$0.81
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Andrew Ritter
Region: US
Website: https://www.qualigeninc.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.qualigeninc.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news